Speaking at the event, 'The Nobel Prize to Now: building a legacy of discovery to tackle AMR', Prof McShane reflects on why we so urgently need new antibiotics to treat drug-resistant tuberculosis, and how therapeutic vaccines can be used to combat the world's most devastating pathogen.
To tackle this global health threat, the Ineos Oxford Institute for Antimicrobial Research (IOI) has awarded £5m for the establishment of an Oxford consortium to develop new therapies for TB.
Watch Prof McShane's talk here: IOI Grand Challenge: Tuberculosis